Serotonin and thrombotic complications
- PMID: 1717768
Serotonin and thrombotic complications
Abstract
We believe that the abrupt conversion from chronic stable to unstable angina and the continuum to acute myocardial infarction may result from myocardial ischemia caused by progressive platelet aggregation and dynamic vasoconstriction themselves caused by local increases in thromboxane and serotonin at sites of coronary artery stenosis and endothelial injury. Platelet aggregation and dynamic coronary artery vasoconstriction probably result from the local accumulation of thromboxane and serotonin and also relative decreases in the local concentrations of endothelially derived vasodilators and inhibitors of platelet aggregation, such as endothelium-derived relaxing factor (EDRF) and prostacyclin. With severe reductions in coronary blood flow caused by these mechanisms, platelet aggregates may increase, and an occlusive thrombus composed of platelets and white and red blood cells in a fibrin mesh may develop. When coronary arteries are occluded or narrowed for a sufficient period of time by these mechanisms, myocardial necrosis, electrical instability, or sudden death may occur. We believe that unstable angina and acute myocardial infarction are a continuum in relation to the process of coronary artery thrombosis and vasoconstriction. When the period of platelet aggregation or dynamic vasoconstriction at sites of endothelial injury and coronary artery stenosis is brief, unstable angina or non-Q-wave infarction may occur. However, when the coronary artery obstruction by these mechanisms is prolonged for several hours. Q-wave myocardial infarction results. Chronic endothelial injury and coronary artery stenosis are probably associated with the accumulation of platelets, white and red blood cells, and a fibrin mesh at the site of stenosis and endothelial injury.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.Circulation. 1989 Jul;80(1):198-205. doi: 10.1161/01.cir.80.1.198. Circulation. 1989. PMID: 2661053 Review.
-
Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction.Tex Heart Inst J. 1990;17(3):157-64. Tex Heart Inst J. 1990. PMID: 15227166 Free PMC article.
-
Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.Rev Port Cardiol. 1994 Dec;13(12):935-46, 893. Rev Port Cardiol. 1994. PMID: 7873224 Review.
-
Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators.Tex Heart Inst J. 1991;18(4):243-7. Tex Heart Inst J. 1991. PMID: 15227406 Free PMC article.
-
Myocardial cellular alterations during myocardial ischemia and evolving infarction.Postgrad Med. 1988 Feb 29;Spec No:69-75. Postgrad Med. 1988. PMID: 2894662 Review.
Cited by
-
Curing the incurable: A case of refractory vasospastic angina.Ann Med Surg (Lond). 2021 Sep 15;71:102869. doi: 10.1016/j.amsu.2021.102869. eCollection 2021 Nov. Ann Med Surg (Lond). 2021. PMID: 34703580 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous